Editor’s note: This is an automatically generated transcript. Please notify editor@healio.com if there are concerns regarding accuracy of the transcription. We're excited in the multiple myeloma that ...
B-cell maturation antigen (BCMA) is encoded by the TNFRSF17 gene found on the short arm of chromosome 16. BCMA is a type III transmembrane glycoprotein primarily expressed on the surface of myeloma ...
Neoantigens are unique markers that distinguish only cancer cells. By adding B cell reactivity, cancer vaccines can move ...
Immune cells called B cells make antibodies that fight off invading bacteria, viruses and other foreign substances. During ...
The Chosun Ilbo on MSN
KAIST unveils B-cell targeting AI cancer vaccine
The fear of cancer stems from the dread that it can recur at any time, even after treatment. A South Korean research team has ...
Sequential Infusion of Mesenchymal Stem Cell for Graft-Versus-Host Disease Prevention in Haploidentical Hematopoietic Stem Cell Transplantation: An Open-Label, Multicenter, Randomized Controlled ...
Immune cells called B cells make antibodies that fight off invading bacteria, viruses and other foreign substances. During ...
In a clinical trial of 7 patients, anti-BCMA only CAR-T cell treated patients with refractory lupus nephritis safely and effectively. Anti-B cell maturation antigen (BCMA)-targeting chimeric antigen ...
ADEL-Y01, a monoclonal antibody targeting tau protein, is in Phase I trials for Alzheimer's disease, developed by ADEL and licensed to Sanofi. The ADEL-Sanofi agreement is valued at over $1.04 billion ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback